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ABSTRACT 
Introduction: The association of anti phospholipid antibodies (APA) with Non..Hodgkin 
Lymphoma~) has been reported and complete remission was associated with 
disappearance of APA. APA are autoantibodies which include anticardiolipin antibody 
(ACA), anti-beta2-glycoprotein-I (~2 GPI) antibodies and lupus anticoagulant (LA). 
Objective: The purpose of this study was to determine the prevalence of APA 
and its clinical association among NHL patients in our institution. 
Meth~dology: A study was conducted ~n Hospital· Unive~sity Science Malaysia 
. . .. . 
(HUSM) between June 2003 and July 2004. Fifty-three selected NHL patients · 
were tested for ACA and anti-~2 GPI at presentation using ELISA technique. 
They were followed-u'p over a median period of 6 months to detect the 
occurrence of thromboembolism (TE} and bone marrow recovery following 
chemotherapy using full blood counts. 
Results: APA was found in 23 out of 53 NHL patients, with ACA 35.8o/o and anti-
(32 GPI antibodies 18.9o/o. The incidence of elevated APA was increased after 40. 
years old (91.3°/o). However, positivity for APA was not associated with gender, 
survival, histology or stage of lymphoma. There were three patients who 
developed TE and all of them were ACA positive. Positive APA was found to 
correlate with thrombocytopenia at presentation (p= 0.032) and associated with 
poor platelet recovery following chemotherapy (p=0.001 ). 
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Conclusion: APA was common among NHL patients especially after 40 years 
old. Although no statis~ical association was found between APA positive NHL and 
thrombosis, there was a tendency forTE to occur in APA positive NHL. 
Key words: Antiphospholipid antibodies; anti-beta2-glycoprotein-l antibodies; 
anticardiolipin antibodies; non-Hodgkin Lymphoma. 
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Introduction 
Thromboembolism (TE) and autoimmune phenomena are often seen in 
patients with NHL. Among all the malignant tumors, lymphoma patients are the 
fourth most likely population at risk to significant morbidity and mortality related to 
thrombosis 1 . The association of APA has been reported in several cases of 
patients with NHL, with or without thromboembolic complications2. In previous 
studies, complete remission was associated with disappearance of APA after 
treatmene. 
APA are autoantibodies with specificity towards negatively charged 
phospholipids that include ACA~ anti-~2 GPI and LA 4. The association of APA 
with recurrent venous or arterial thrombotic events, thrombocytopenia and fetal 
loss has been well established and is known as antiphospholipid syndrome 
(APS)5. In one study, increased incidence of vascular thrombosis among APA 
positive cancer patients (22°/o) was reported6 . 
According to Malaysia National Registry 2002, lymphoma ranked seventh 
amongst male cancer and eleventh amongst the female cancers in Malaysia. 
Lymphoma constituted 3. 7°/o of all cancers in Malaysia. There was male 
preponderance of 3:2. Ratio of Hodgkin to NHL is 1:9. In NHL, the male to female 
ratio was 1.4: 1. The peak incidence of both sexes was in the age group 60-69 
7 years . 
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The present study was designed to explore the prevalence and clinical 
associations of elevated APA titers (ACA and anti-~2 GPI) in patients affested-GY-
NHL in our institution. It is hoped that this study will clarify the clinical 
descriptions of APA in NHL. Because of the potential APA test to influence 
therapy, routine testing for APA can be justified in NHL patients if statistically and 
clinically found to be significant. 
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Patients and methods 
The study was conducted prospectively during one-year period. The 
participants were patients with active disease either newly diagnosed or relapsed 
non-Hodgkin lymphoma, admitted to medical and pediatric wards in Hospital 
University Science Malaysia for treatment. The·study-was. conducted-Between 
Jun 2003 and July 2004.· 
This study was approved by the ethical committee; School of Medical· 
Sciences, University ·science of-Malaysia. Each patient's .serum was examined 
for the presence of anticardiolipin antibodies (lgM & lgG) and anti-r!,2 GPI 
antibodies (lgM & lgG) by commercially available enzyme-linked immunosorbent 
assay (ELISA). All cases were followed-up for at least 6 months to look for the 
TE 
development of thr~oembolism and bone marrow recovery following the 
treatment yvith conventional chemotherapy according to the type of NHL. 
Peripheral cell count is a good indicator of mar~ow recovery and blood were 
taken randomly after chemotherapy when the counts were expected to 
normalize. The expected recovery time is 3 to 4 weeks following the first day of 
chemotherapy or just before the patient entered the next cycle of chemotherapy. 
Duration for 6 months follow-up was chosen in view of patients were expected to 
complete the treatment at that time or possibly already achieved some 
remissions. 
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The study group consisted of 53 _NHL cases, regardless of the age, 
~thnicity and histological findings. Diagnosis was m~de based on 
histopathological examination (HPE) findings from lymph node or tissue biopsy. 
The histological classification was based on Working Formulation and were 
staged according to Ann Arbor staging system. Complete staging by CT scan 
and bone marrow biopsy were carried out. 
Inclusion criteria for study group 
·. 1- All NH~ cases (pediatric & adult). · 
· . · :.-~xclusion c.riteria for study·g.to_up .. \I 
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1- ·Patients with chronic. infection eg. Hep C, HIV and syphilis~ 
2- Patients with active infection receiving treatment (antibiotics). 
3- Patients on drugs that had been . documented to be related with 
development of APA 
The cases were approached and consents obtained for blood taking. 
Blood samples were collected by venipuncture into three containers, one 
containing 1/10 volume 3.8°/o sodium ·citrate for D-dimer and the other is 1/10 
volume O.SM sodium EDTA for Direct Coombs test and 2cc plain bottle for 
immunoassay (ELISA). Direct Coombs test and D-dimer were analyzed on the 
same day of blood collection. Blood in plain bottle were allowed to clot naturally 
and the serum separated after centrifugation. After centrifugation, the serum was 
stored at -34°C until batch analysis. Test for D-dimer was done to look at the 
possibility of occult TE that might occur in these cases. Direct Coombs test was 
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underlying autoimmune activity reJated to NHL. 
The immunoassay was intended for in-vitro measurement of lgG/IgM 
autoantibodies against" cardiolipin and f32 GPI in human serum,··as-an.aid-in-the 
diagnosis~·of·antiphospholipid-syrfdrome. These antibodies concentrations were 
measured by a commercially· available ELISA technique produced by The 
Binding Site_Ltd-UK. Microw~lls are·p~e~coated·w.ith cardiolipin or B2 GPI. 
- C81i.brat6rs;; cb~t~~~~ a~~ P~tiEi~fsarnpi~S ~~·aiid~ct tot~~ \"'ells '~nd : . 
• •• :~- ::...: -· -~ ' • • ~ • 1 • ' •• : ~·. • • • 
~uto~ntibodies recogJJ·i~ing. cil~di~lip.in .. t)i·nd. d·u.;ing the fi~~t· incub~tion. After 
washing the ~ells to f~ni?~e.all_unbound proteins, peroxidase la~eled rabbit anti-
human lgG antibody c~njugate· was added. The conjugate binds to the captured 
human antibody and the excess unbound conjugate was removed by further 
wash step. The bound conjugate was visualize~ with tetramethylbenzidine (TMB) 
substrate that gives a .. blue reaction product, the intensity of which is proportional 
to the concentration of autoantibody in the .sample. Phosphoric acid was added 
to each well to stop the reaction. This produces yellow end point colour,.wh_ich 
was read at 450nm.lnterpretation of results was done by semiquantitative 
methods (according to the manufacturer's recommendations). 
The D-Di test® (Diagnostica Stago, France) is a rapid latex agglutination 
slide test using mouse monoclonal antibodies for the qualitative and semi-
quantitative determination of D-dimer in plasma. The latex particles provided in 
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• the test are coated with mouse anti-human 0-dimer monoclonal antibodies. Test 
sample containing D-dimers when mixed with the latex particle suspension make 
the particles to agglutinate. Citrated plasma was used for testing. Samples were 
centrifuged for 1 Ominutes at 2500g and supernatant were collected. Undiluted 
plasma and 1:1 dilution plasma were mixed with one drop of latex suspension on 
a glass slide and the slide was gently rocked for 2 minutes. Interpretation of the 
test was done as recommend~d by the manufacturer. Agglutination indicates 
positive results. 
The oct or direct antiglobulin test. is a technique that can be used to 
detect for the presence of immunoglobulins or complement that have been bound 
to the red cells in vivo. This test was done by adding antihuman globulin to red 
cells of the patient's blood suspended in saline. The presence of agglutination in 
the samples after spinning indicate positive OCT, indicating the presence of 
. surface immunoglobulin or complement component that have been bound to the 
red cells. Polyspecific antihuman globulin (AHG) contain antibody to human lgG 
and the C3d component of human complement and may also react weakly with 
lgA and lgM molecules due to anti-light chain activity. The reagent used was 10-
-
card "DC-Screening II" produced by Diamed consisting of polyspecific AHG 
. reagent. Patients with auto-immune haemolytic anaemia (AIHA) may give 
positive results. 
12 
, . 
For full blood count (FBC), the determination of haemoglobin level (Hb), 
Total white blood cell (TWC) count and platelet count was done by using 
automated Hematological Analyzer, Sysmex KX-21 N. 
All data were analyzed using the statistical package programmed for 
10 
social sciences (SPSS) software version 11.0 for windows. The proportion was 
calculated as 95°/o confidence interval (CI). The differences of various 
parameters, between APA positive and negative patients were evaluated using 
Chi square or Fisher's exact test when applicable with level of significance, p < 
· 0.05. The degree of assqciation was presented by odd ratio (00) and its 95.0/o Cl 
and relative risk (RR) and its 95°/o Cl as appropriate 
13 
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Results 
There were 53 cases altogether, including 5 paediatric patients and 48 
adult patients. 
Patient's characteristics: 
Patient's characteristics are summarized in Table 1. The median age of 
the group was 41.5 year (range 3-80 year). Early disease was defined as stage 1 
or II while advanced stage as stage Ill and IV. At the time of the last contact, 7 
patients were dead. Causes o(death were attributed to complications of sepsis. 
. .. 
Detection of APA: 
All 53 patients were tested for the presence of 4 types of antiphospholipid 
antibodies (lgM and lgG anticardiolipin antibodies, anti-lgG and anti-lgM ~2 
Glycoprotein I antibodies). Twenty-three patients out of 53 (4_3.4°/o) showed a 
positivity for at least one of the APA. The proportion of APA in patients with NHL 
was calculated as 95°/o confidence interval is 43.4°/o (95°/oCI:30.3°/o, 57.2°/o). Ten 
patients (18.9°/o) were positive for anti-~2GP1 antibodies and 19 patients (35.8°/o) 
were positive for ACA. Five patients (9.4°/o) were positive for both antibodies. 
Details are given in Table 2 and the summary of laboratory data of 23 patients 
with positive APA is shown in table 3. 
Association between APA positivity and haematological parameters: 
The summary of haematological data of all subjects is shown in table 4. 
14 
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The association between APA positivity and available haematological parameters 
were tested by using x!- (Chi square) test and the degree of association was 
presented by odd ratio (OR) and its 95°/oCI and relative risk (RR) and its 95o/aCI 
as appropriate. We found that from crosstabs descriptive statistical analysis 
(SPSS version 10.0), there was significant association between positive APA and 
development of thrombocytopenia at presentation (p=0.032) and poor platelet 
recovery post chemotherapy (p value=0.001 ). However, there was no significant 
association of APA positivity and other laboratory parameters such as Coombs 
. I • 
test, 0-dfmer, hb level and TWC count (p value>0.05). 
Association between APA and age, gender, histology, stage of Lymphoma 
and patient's survival. 
The results and statistical analysis are shown in table 5. 
There were a greater proportion of men than women among 23 patients with 
elevated APA. The median age of the·24 patients with positive APA was 48.5 
year. From statistical analysis by Fisher exact test, there was a significant 
association between patient's age and APA positivity (p value:;:: 0.002). However 
there was no association between APA positivity and sex, stage of disease, 
histology, survival and bone marrow infiltration noted. 
Association of APA and thrombosis 
TE events were observed in three out of 53 patients (5.7°/o), all of them 
were positive for APA. Three TE events that were observed are pulmonary 
15 
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• embolism (diagnosed by pulmonary scan angiography), ishaemic_heart disease 
(anteroseptal ishaemia by ECG) and deep vein thrombosis (right superficial 
femoral vein thrombosis diagnosed by Doppler ultrasound). Thrombosis occurred 
in two patients with high grade NHL and one with low grade NHL. All three 
patients with TE were positive to anticardiolipin antibodies with weak to moderate 
positivity. None are positive to anti-~2 GPI antibodies. The clinical and laboratory 
data of these patients are summarized in Table 6. The association between APA 
positivity and occurrence of thromboembolism was tested by using Fisher exact 
tests· and the degree of association was presented by relative risk (RR) and its 
95°/oCI as appropriate. We also tested with simple logistic regression and the 
same results as analysed by Fisher exact test was obtained. We did not fi~d any 
significant differences- in occurrence of thromboembolism among the subjects 
with either positive or negative for APA (p value=0.076). 
16 
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Discussion 
In NHL patients, whether autoimmune antibodies contribute to 
pathogenic relevance is still controversial. There was one study to determine the 
autoimmune phenotype of 64 NHL patients by using Coombs test, platelet 
autoantibodies, antiphospholipid antibodies, anti-nuclear antibodies and LA as 
autoimmune markers. They found 39 o/o of patients displayed one or more 
autoimmune marker positivity. They observed median survival was longer in 
autoimmune marker negative patients than in the positive counterpart. No 
significant association between this autoimmune marker positivity with sex and 
remi!?Sion rate~8. We found 60.3°/o of NHL patients exhibit one or more 
autoimmune markers. It is difficult for us to compare the median survival between 
positive and negative autoimmune markers of NHL patients in our study because 
of the short follow-up period. 
The relationship between lymphoproliferative disorder and autoimmunity 
is well documented. A Study by Zuckerman et al, noted the prevalence of ACA 
was 39°/o in non-Hodgkin lymphoma6 . Patient with certain autoimmune disorders 
such as systemic lupus erythematosus have several fold increased risk for 
development of malignant lymphoma9 . A four-year prospective study from the 
Italian Registry reveals that hematological malignancies can develop during 
follow-up in patients with positive for APA. They found four out of 360 of their 
APA patients had developed NHL10 . In our study, APA was detected in 43.4o/o of 
NHL cases; which is slightly higher to the previous studies reported. A 
17 
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prevalence of 16.6°/o anti-~2GP-1 was reported in NHL patients2. In this study we 
found 18.9°/o were positive for this antibody. The conditions associated with 
alloantibody development, particularly infectious diseases, were not identified 
during sample collection, thus suggesting that APA activities in these subjects 
are indeed autoantibodies in relation to underlying NHL. 
There have been several studies published which have estimated the 
prevalence of APA in NHL. Stasi et al explored ACA ahd LA among r~cently 
diagnosed high-grade NHL patients and reported a prevalence of 35.7o/o, 
whereas Genvresse et al and Zuckerman et al reported a prevalence of 26.6o/o 
and 39°/o of APA in their study respectively3•2•6. In addition to NHL, other 
conditions associated with the development of auto-antibodies have to be 
considered to explain the slightly high prevalence of APA in our study compared 
to their study. High prevalence of APA in our study is unlikely due to infection or 
" 
due to certain. drugs because none of the subjects were reported to have any 
clinically overt infectious diseases or on any drugs that can cause false· positive 
APA during sample collection. However we cannot rule out the hypothesis of a 
possible relationship between APA positivity and some drugs or unknown 
infectious agent. 
Our results showed that there was a significant association between 
APA positivity and patient's age (p value <0.05). Majority of patients that had 
elevated APA are from age group more than 40 years old. As with other 
18 
antibodies, the prevalence of APA increases with age, especially in elderly 
patients with coexistence chronic diseases. 
Ten percent of patients with Hodgkin and non-Hodgkin lymphoma are 
at risk of thromboem.bolism 1. In our case, the venous thromboembolic event is 
about 5. 7°/o. We observed three patients developed TE during follow-up and all 
of them were positive for ACA. This is an important observation although the 
findings did not reach statistical significance. 
Although APS has been described primarily with elevated lgG 
antibodies but it also occurs with elevated lgM antibodies 11 . Therefore mul!iple 
tests for APA should be used since patients may be negative according to one 
test yet positive according to another. Levels of lgG ACA greater than 40 units 
have been linked to increased risk of thromboses 10. However one study 
suggested t~at the presence of persistent positivity regardless of the APA titer 
identifies patients at risk of thromboembolic events 12. A.ntiphospholipid antibody 
mediated thrombosis tends to reccur13. However the information on the 
recurrence TE in APA positive NHL is limited. There was one case-control study 
looking at the risk of thrombosis in healthy patients with ACA and they found a 
significant association between elevated ACA titers with DVT and PE but not with 
ischemic stroke 14 · However a few prospective studies have shown an association 
between APA and first episode of venous thrombosis, first myocardial infarction 
and recurrent stroke 11 . In our study, ishaemic heart disease occurrence in one of 
19 
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the patients may be directly or indirectly related to APA. Our observation in this 
study is important since all the three patients who developed TEare positive for 
ACA. 
None of our 9 NHL patients with anti-(32 GPI antibodies developed a 
thrombosis during follow-up. Previously Genvresse et al has reported two cases 
of arterial thrombosis associated with ACA and anti-(32GP-1 antibodies in 
patients with NHL15. The lack of occurrence of thrombosis in anti-J32 GPI positive 
NHL patie~tsJ~ this study ma~.be explained by the.ir low ant.i~J32 ·S?PI antibody 
titers or only one marker (anti-~2 GPI) which was detected positive. 
We obsenied a significant association between the incidence of APA 
and development of thrombocytopenia at presentation (p=0.032) and post 
chemotherapy. (p= 0.001 ). This indicates that cell recovery after chemotherapy 
may be affected particularly platelet count in APA positive NHL patients. We also 
found that NHL patients with positive APA are five fold at risk (Relative risk= 5.2) 
to develop thrombocytopenia during any course of the disease. This suggests 
that APA positivity may be one of the contributory factors in complicating the 
thrombocytopenia in patients with NHL. Autoimmune thrombocytopenia in 
lymphoproliferative disorder showed a poor response to glucocorticoids 16 . 
l - C'-~ ·.'i·J('{\ ) 
, More systematic studies should be addressed because so far no such study to 
/' .. 
relate between APA positivity and peripheral cells recovery post chemotherapy. 
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In our study, bone marrow infiltration and other causes of thrombocytopenia for 
example active infection and OIC were excluded. 
0-dimer levels are typically elevated in the plasma of patients with 
acute thrombosis. 0-dimer assays have been advocated to exclude underlying 
TE on the basis of a normal test results. Although 0-Dimer assays have high 
negative predictive values for the diagnosis of deep vein thrombosis, their 
accuracy in patients with cancer is uncertain 17• We found 37. 7o/o were positive for 
D~dimer at presentation but none of them had symptomatic thrombosis. Looking 
to our three patients with TE, one patient was negative for 0-dimer. One of the 
most clear-cut reasons for this patient to have negative 0-dimer in the presence 
of TE is a false normal result, due to low concentration of 0-dimer for the cut-off 
value to be reached. A negative D-dimer test result in patients with cancer does 
not reliably exclude deep vein thrombosis because the negative predictive value 
is significantly lower in these patients than in patients without cancer17 . 
B cell lymphomas and leukaemias are the malignancies most 
frequently associated with autoimmune haemolytic anaemia 16 . In this study we 
found that 50.9°/o of our NHL patients had positive direct Coombs test (OCT). A 
positive test results must be correlated with clinical or laboratory evidence of 
haemolysis since positive OCT can occur in many conditions. High positive DCT 
was observed in hospitalized patients 18. In this study we observed only one case 
21 
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of autoimmune haemolytic anemia that developed concurrently with NHL. 
However, this patient was negative for APA. 
We have identified a few limitations in our study. One potential 
limitation of our study is the fact that we did not perform LA test. As LA and 
elevated ACA occurred concurrently in 30o/o of cases, therefore the combined 
use of the two methods should be advocated3 . More sample size should be 
considered with longer follow-ups to observe for the TE complications in future. 
However APA.was prevalent among. our NHL patients (43.4%) and .in subjects 
more than 40 years old. Although statistically there is no significant between APA 
positivity and occurrence of TE, we observed that all three patients with 
thromboembolic events were positive for ACA. 
In conclusion, the association between TE and APA remains 
uncertain from this study. Our results were compatible with a wide range of 
effects including substantial decreased and increased in TE. A larger sample size 
would enable a definite conclusion regarding this relationship. However we 
proposed that it is still beneficial to detect these antibodies in selected NHL 
patients particularly with TE events. This could improve the diagnosis and aid in 
the management of TE, for example to monitor for the risk of recurrence. Poor 
recovery of platelet count post chemotherapy or during follow-up in the absence 
of bone marrow infiltration may indicate an underlying co-existing APA 
22 
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_particularly in older NHL patients. Hence, confirming its presence could help in 
the patient'~ management especially in cases with severe thrombocytopenia. 
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